| __timestamp | Geron Corporation | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 15635076 |
| Thursday, January 1, 2015 | 17831000 | 23943601 |
| Friday, January 1, 2016 | 18047000 | 23689111 |
| Sunday, January 1, 2017 | 11033000 | 41006114 |
| Monday, January 1, 2018 | 13432000 | 51379106 |
| Tuesday, January 1, 2019 | 52072000 | 32705593 |
| Wednesday, January 1, 2020 | 51488000 | 53274000 |
| Friday, January 1, 2021 | 85727000 | 85352000 |
| Saturday, January 1, 2022 | 95518000 | 51999000 |
| Sunday, January 1, 2023 | 125046000 | 59471000 |
Data in motion
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Summit Therapeutics Inc. and Geron Corporation have been at the forefront of this transformative journey. From 2014 to 2023, Geron Corporation's R&D expenses surged by nearly 500%, peaking in 2023. This reflects a strategic focus on pioneering treatments in oncology. Meanwhile, Summit Therapeutics Inc. demonstrated a steady commitment to R&D, with a notable 280% increase from 2014 to 2021, before a slight decline in subsequent years. This trend underscores the dynamic nature of biotech investments, where companies must balance innovation with financial sustainability. As the industry continues to evolve, these investments highlight the relentless pursuit of breakthroughs that could redefine healthcare.
Pfizer Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Zoetis Inc. or Geron Corporation: Who Invests More in Innovation?
United Therapeutics Corporation or Geron Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Insmed Incorporated
R&D Spending Showdown: Summit Therapeutics Inc. vs Sarepta Therapeutics, Inc.
Summit Therapeutics Inc. or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development Investment: Summit Therapeutics Inc. vs BioCryst Pharmaceuticals, Inc.
Insmed Incorporated vs Geron Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and Geron Corporation
Analyzing R&D Budgets: Lantheus Holdings, Inc. vs Geron Corporation
Analyzing R&D Budgets: Ligand Pharmaceuticals Incorporated vs Geron Corporation
Research and Development Investment: Geron Corporation vs BioCryst Pharmaceuticals, Inc.